comparemela.com

Page 3 - Biocryst Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioCryst Pharmaceuticals (BCRX) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. The firm currently has a $12.00 price objective on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Royal […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.